Page last updated: 2024-09-03

sr 48692 and Melanoma

sr 48692 has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, H; Liu, Y; Yi, L; Zhang, Y; Zhu, S	1

Other Studies

1 other study(ies) available for sr 48692 and Melanoma

Article	Year
Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells. Molecular and cellular biochemistry, 2014, Volume: 389, Issue:1-2 Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Keratinocytes; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; Tumor Cells, Cultured	2014

Article

Year

Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.

Molecular and cellular biochemistry, 2014, Volume: 389, Issue:1-2

Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Keratinocytes; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; Tumor Cells, Cultured

2014